⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVTX News
Avalo Therapeutics, Inc. Common Stock
Avalo Therapeutics Appoints Ron Philip to Board of Directors
globenewswire.com
AVTX
Form 8-K
sec.gov
AVTX
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
globenewswire.com
AVTX
Form 8-K
sec.gov
AVTX
Form 8-K
sec.gov
AVTX
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AVTX
Form 8-K
sec.gov
AVTX
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
globenewswire.com
AVTX
Form 8-K
sec.gov
AVTX
Avalo Therapeutics Announces Pricing of $375 Million Public Offering
globenewswire.com
AVTX